Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Angiogenesis in liver metastasis of colo-rectal carcinoma.

Xu B, Shen F, Cao J, Jia L.

Front Biosci (Landmark Ed). 2013 Jun 1;18:1435-43. Review.

PMID:
23747894
2.

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.

Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM.

Cancer. 2000 Aug 1;89(3):488-99.

PMID:
10931447
3.

Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor.

Goi T, Fujioka M, Satoh Y, Tabata S, Koneri K, Nagano H, Hirono Y, Katayama K, Hirose K, Yamaguchi A.

Cancer Res. 2004 Mar 15;64(6):1906-10.

4.

Angiogenesis of liver metastases: role of sinusoidal endothelial cells.

Gervaz P, Scholl B, Mainguene C, Poitry S, Gillet M, Wexner S.

Dis Colon Rectum. 2000 Jul;43(7):980-6.

PMID:
10910247
5.

Morphologic analysis of microvessels in colorectal tumors with respect to the formation of liver metastases.

Yamamura T, Tsukikawa S, Yamada K, Yamaguchi S.

J Surg Oncol. 2001 Dec;78(4):259-64.

PMID:
11745821
6.

Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.

Fernando NT, Koch M, Rothrock C, Gollogly LK, D'Amore PA, Ryeom S, Yoon SS.

Clin Cancer Res. 2008 Mar 1;14(5):1529-39. doi: 10.1158/1078-0432.CCR-07-4126.

7.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
8.

Preclinical data targeting vascular endothelial growth factor in colorectal cancer.

Ellis LM.

Clin Colorectal Cancer. 2004 Oct;4 Suppl 2:S55-61. Review.

PMID:
15479480
9.

Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.

Nakamoto RH, Uetake H, Iida S, Kolev YV, Soumaoro LT, Takagi Y, Yasuno M, Sugihara K.

Jpn J Clin Oncol. 2007 Sep;37(9):679-85. Epub 2007 Sep 10.

PMID:
17846040
10.

[Significance of p53 and VEGF expression in liver metastasis from colorectal cancer].

Yamamura T, Matsuzaki H, Ozasa T, Matsuoka H, Tanaka K, Oikawa H, Akaishi O, Tsukikawa S, Yamaguchi S.

Gan To Kagaku Ryoho. 1998 Jul;25(9):1355-7. Japanese.

PMID:
9703827
11.

Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.

Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF, Ellis LM.

Cancer Res. 2003 May 1;63(9):2079-87.

12.

Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.

Kern A, Taubert H, Scheele J, Rudroff C, Mothes H, Kappler M, Bartel F, Richter KK.

Int J Oncol. 2002 Aug;21(2):243-9.

PMID:
12118317
13.

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.

Ninomiya I, Nagai N, Oyama K, Hayashi H, Tajima H, Kitagawa H, Fushida S, Fujimura T, Ohta T.

Oncol Rep. 2012 Sep;28(3):777-84. doi: 10.3892/or.2012.1885. Epub 2012 Jun 26.

14.

Three-dimensional growth as multicellular spheroid activates the proangiogenic phenotype of colorectal carcinoma cells via LFA-1-dependent VEGF: implications on hepatic micrometastasis.

Valcárcel M, Arteta B, Jaureguibeitia A, Lopategi A, Martínez I, Mendoza L, Muruzabal FJ, Salado C, Vidal-Vanaclocha F.

J Transl Med. 2008 Oct 9;6:57. doi: 10.1186/1479-5876-6-57.

15.

[Angiogenesis and cancer: from biopathology to therapy].

Graça B, Lunet C, Coelho AS, Monteiro G, Freire P, Speidel A, Carvalho L.

Acta Med Port. 2004 Jan-Feb;17(1):76-93. Epub 2004 Feb 27. Review. Portuguese.

16.

[Liver metastasis in colorectal cancer and tumor angiogenesis].

Xie Z, Huang X, Li J, Zhou L.

Zhonghua Wai Ke Za Zhi. 1999 Jun;37(6):336-7, 21. Chinese.

PMID:
11829853
17.

Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.

Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST.

Clin Cancer Res. 2010 Feb 1;16(3):967-77. doi: 10.1158/1078-0432.CCR-09-1487. Epub 2010 Jan 26.

18.

Role of angiogenesis in the development and growth of liver metastasis.

Takeda A, Stoeltzing O, Ahmad SA, Reinmuth N, Liu W, Parikh A, Fan F, Akagi M, Ellis LM.

Ann Surg Oncol. 2002 Aug;9(7):610-6. Review.

PMID:
12167573
19.

[Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer].

Zhou ZW, Wan DS, Wang GQ, Ren JQ, Lu ZH, Tang SX, Ye YL, Chen G, Lin SX.

Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Mar;9(2):161-4. Chinese.

PMID:
16555161

Supplemental Content

Support Center